JPRN-UMIN000006726尚未招募未知
A study of Tolvaptan to investigate the pharmacokinetics and diuretic effect - A study of Tolvaptan to investigate the pharmacokinetics and diuretic effect
Kanagawa Children's Medical Center0 个研究点目标入组 10 人开始时间: 2011年11月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 10years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. patients who have circulation assist 2. patients who have diseases, complications or symptoms as follows: *possibly hypovolemic *hypertrophic cardiomyopathy *hepatic coma *severe diabetes *anuria *urinary stenosis, calculus or impairment of urinary excretion due to tumor 3. patients who have a history as follows: *cerebrovascular disease (asymptomatic is excluded) *patients who have a history of allergy against benzazepine 4. patients whose laboratory test are as follows(at least 1 item) *total bilirubin >3.0mg/dL *serum creatinine >3.0mg/dL *serum Na >147mEq/L *serum K >5.5mEq/L 5. patients who are judged to be inappropriate to this study
研究者
相似试验
招募中
不适用
A study to evaluate effect and safety of Tolvaptan in Nephrogenic Diabetes Insipidus caused by mutations in the vasopressin type 2 receptor gene.ephrogenic Diabetes Insipidus caused by mutations in the vasopressin type 2 receptor geneJPRN-UMIN000021708Department of Nephrology and Endocrinology, The University of Tokyo Hospital3
已完成
不适用
Study of the safety and efficacy of tolvaptan for fluid retention symptoms of right heart failure due to pulmonary hypertensiopulmonary hypertensionJPRN-UMIN000010196Department of Cardiology, Keio University School of Medicine40
尚未招募
4 期
A study on the safety and efficasy of tolvaptan for patients with fluid retention after cardiothoracic surgeryPatients received cardiothoracic surgery with congestive heart failure.JPRN-UMIN000011172Osaka city university graduate school of medicine210
已完成
3 期
A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADHSyndrome of Inappropriate Antidiuretic Hormone SecretionNCT03048747Otsuka Pharmaceutical Co., Ltd.16
已完成
不适用
ongitudinal Efficacy and Safety Study of Tolvaptan on Autosomal Dominant Polycystic Kidney Disease PatientsAutosomal Dominant Polycystic Kidney DiseaseJPRN-UMIN000021267Autosomal Dominant Polycystic Kidney Disease Research Section, Kyorin University, School of Medicine119